These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 17671228)

  • 1. Cervicovaginal levels of lactoferrin, secretory leukocyte protease inhibitor, and RANTES and the effects of coexisting vaginoses in human immunodeficiency virus (HIV)-seronegative women with a high risk of heterosexual acquisition of HIV infection.
    Novak RM; Donoval BA; Graham PJ; Boksa LA; Spear G; Hershow RC; Chen HY; Landay A
    Clin Vaccine Immunol; 2007 Sep; 14(9):1102-7. PubMed ID: 17671228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of pregnancy on anti-HIV activity of cervicovaginal secretions.
    Hughes BL; Dutt R; Raker C; Barthelemy M; Rossoll RM; Ramratnam B; Wira CR; Cu-Uvin S
    Am J Obstet Gynecol; 2016 Dec; 215(6):748.e1-748.e12. PubMed ID: 27393267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacterial vaginosis, not HIV, is primarily responsible for increased vaginal concentrations of proinflammatory cytokines.
    Mitchell CM; Balkus J; Agnew KJ; Cohn S; Luque A; Lawler R; Coombs RW; Hitti JE
    AIDS Res Hum Retroviruses; 2008 May; 24(5):667-71. PubMed ID: 18462081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacterial Vaginosis and Subclinical Markers of Genital Tract Inflammation and Mucosal Immunity.
    Thurman AR; Kimble T; Herold B; Mesquita PM; Fichorova RN; Dawood HY; Fashemi T; Chandra N; Rabe L; Cunningham TD; Anderson S; Schwartz J; Doncel G
    AIDS Res Hum Retroviruses; 2015 Nov; 31(11):1139-52. PubMed ID: 26204200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High Levels of Inflammatory Cytokines in the Reproductive Tract of Women with BV and Engaging in Intravaginal Douching: A Cross-Sectional Study of Participants in the Women Interagency HIV Study.
    Alcaide ML; Rodriguez VJ; Brown MR; Pallikkuth S; Arheart K; Martinez O; Roach M; Fichorova RN; Jones DL; Pahwa S; Fischl MA
    AIDS Res Hum Retroviruses; 2017 Apr; 33(4):309-317. PubMed ID: 27897054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant cervical innate immunity predicts onset of dysbiosis and sexually transmitted infections in women of reproductive age.
    Fichorova RN; Morrison CS; Chen PL; Yamamoto HS; Govender Y; Junaid D; Ryan S; Kwok C; Chipato T; Salata RA; Doncel GF
    PLoS One; 2020; 15(1):e0224359. PubMed ID: 31914129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short communication: genital tumor growth factor-β1 levels in HIV-infected Indian women are associated with reduced levels of innate antimicrobial products and increased HIV shedding.
    Thakar M; Patil R; Shukre S; Bichare S; Kadam P; Khopkar P; Ghate M; Paranjape R
    AIDS Res Hum Retroviruses; 2014 Jul; 30(7):648-53. PubMed ID: 24547777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The lower genital tract microbiota in relation to cytokine-, SLPI- and endotoxin levels: application of checkerboard DNA-DNA hybridization (CDH).
    Nikolaitchouk N; Andersch B; Falsen E; Strömbeck L; Mattsby-Baltzer I
    APMIS; 2008 Apr; 116(4):263-77. PubMed ID: 18397461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomarkers of Cervical Inflammation and Immunity Associated with Cervical Shedding of HIV-1.
    Mauck C; Chen PL; Morrison CS; Fichorova RN; Kwok C; Chipato T; Salata RA; Doncel GF
    AIDS Res Hum Retroviruses; 2016 May; 32(5):443-51. PubMed ID: 26650885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance of swabs, lavage, and diluents to quantify biomarkers of female genital tract soluble mucosal mediators.
    Dezzutti CS; Hendrix CW; Marrazzo JM; Pan Z; Wang L; Louissaint N; Kalyoussef S; Torres NM; Hladik F; Parikh U; Mellors J; Hillier SL; Herold BC
    PLoS One; 2011; 6(8):e23136. PubMed ID: 21858008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Female genital-tract HIV load correlates inversely with Lactobacillus species but positively with bacterial vaginosis and Mycoplasma hominis.
    Sha BE; Zariffard MR; Wang QJ; Chen HY; Bremer J; Cohen MH; Spear GT
    J Infect Dis; 2005 Jan; 191(1):25-32. PubMed ID: 15592999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of menopause on the innate antiviral activity of cervicovaginal lavage.
    Chappell CA; Isaacs CE; Xu W; Meyn LA; Uranker K; Dezzutti CS; Moncla BJ; Hillier SL
    Am J Obstet Gynecol; 2015 Aug; 213(2):204.e1-6. PubMed ID: 25818668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation of interferon-alpha and RANTES in the cervix of HIV-1-seronegative women with high-risk behavior.
    Hirbod T; Nilsson J; Andersson S; Uberti-Foppa C; Ferrari D; Manghi M; Andersson J; Lopalco L; Broliden K
    J Acquir Immune Defic Syndr; 2006 Oct; 43(2):137-43. PubMed ID: 16940859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Limited secretory-IgA response in cervicovaginal secretions from HIV-1 infected, but not high risk seronegative women: lack of correlation to genital viral shedding.
    Fiore JR; Laddago V; Lepera A; La Grasta L; Di Stefano M; Saracino A; Lopalco P; Pastore G; Angarano G
    New Microbiol; 2000 Jan; 23(1):85-92. PubMed ID: 10946410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-1 infection is associated with altered innate pulmonary immunity.
    Gordon SB; Janoff EN; Sloper D; Zhang Q; Read RC; Zijlstra EE; Finn A; Molyneux ME
    J Infect Dis; 2005 Oct; 192(8):1412-6. PubMed ID: 16170759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-HIV activity in cervical-vaginal secretions from HIV-positive and -negative women correlate with innate antimicrobial levels and IgG antibodies.
    Ghosh M; Fahey JV; Shen Z; Lahey T; Cu-Uvin S; Wu Z; Mayer K; Wright PF; Kappes JC; Ochsenbauer C; Wira CR
    PLoS One; 2010 Jun; 5(6):e11366. PubMed ID: 20614007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucosal innate immune factors in the female genital tract are associated with vaginal HIV-1 shedding independent of plasma viral load.
    Cummins JE; Christensen L; Lennox JL; Bush TJ; Wu Z; Malamud D; Evans-Strickfaden T; Siddig A; Caliendo AM; Hart CE; Dezzutti CS
    AIDS Res Hum Retroviruses; 2006 Aug; 22(8):788-95. PubMed ID: 16910835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of immunologic markers in cervicovaginal fluid of HIV-infected and uninfected women: implications for the immunologic response to HIV in the female genital tract.
    Sha BE; D'Amico RD; Landay AL; Spear GT; Massad LS; Rydman RJ; Warner NA; Padnick J; Ackatz L; Charles LA; Benson CA
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Nov; 16(3):161-8. PubMed ID: 9390567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased levels of immune activation in the genital tract of healthy young women from sub-Saharan Africa.
    Cohen CR; Moscicki AB; Scott ME; Ma Y; Shiboski S; Bukusi E; Daud I; Rebbapragada A; Brown J; Kaul R
    AIDS; 2010 Aug; 24(13):2069-74. PubMed ID: 20588163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cervicovaginal secretory antibodies to human immunodeficiency virus type 1 (HIV-1) that block viral transcytosis through tight epithelial barriers in highly exposed HIV-1-seronegative African women.
    Bélec L; Ghys PD; Hocini H; Nkengasong JN; Tranchot-Diallo J; Diallo MO; Ettiègne-Traore V; Maurice C; Becquart P; Matta M; Si-Mohamed A; Chomont N; Coulibaly IM; Wiktor SZ; Kazatchkine MD
    J Infect Dis; 2001 Dec; 184(11):1412-22. PubMed ID: 11709783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.